Presented by:

Chris Nishioka, PhD | Field Applications Scientist, Molecular Devices
Tim Baranowski, PhD | Field Applications Scientist, Molecular Devices
Bas Trietsch, PhD | Chief Technology Officer, MIMETAS
Shannon Mumenthaler, PhD | Professor of Medicine, USC

There has been a recent shift toward using 3D cell models in drug discovery and disease modeling, as numerous studies show they better mimic the i n vivo environment and provide more physiologically-relevant data than 2D models.

In this roundtable discussion, our panel of experts discuss the benefits and inherent challenges of making the transition from traditional 2D high-content assays to more complex 3D biology.

Key highlights:

• Benefits of using 3D cellular models for high-content imaging
• Main barriers to entry into using 3D cell models for high-content imaging and analysis
• Features that will be essential to accelerating high-content imaging of 3D biology

It has been sent to your inbox. If you do not receive an email with the link to the video, please let us know at marketing@moldev.com and a member of our team will email it to you directly.